ARCHIVES

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

This article is from The Cancer Letter archive.

Vol. 19 No. 38 | October 1, 1993

Download PDF Visit The Full Archive

Related Articles

FDA Grants Accelerated Approval To Mekinist-Tafinlar Combination

January 31, 2014

NCI Moves Slowly, Carcinogenesis CANCERGRAMS For May, June Missing

June 1, 1984

In Brief: NCI Thinks Puerto Rico Should Have Comprehensive Center; President Says He Won’t Oppose NIH Budget Increases

April 26, 1974

In Brief: BMS Oncology Names New VP, Marketing; Hortobagyi Wins Freyer Medal; Prerez Honored

October 24, 1997

Linda Weiss, director of NCI Office of Cancer Centers, to Retire in March 2015

November 26, 2014

New Compounds To Treat Gleevec-Resistant CML

January 26, 2007